PRESS RELEASE published on 02/13/2023 at 14:00, 1 year 6 months ago Halberd Corporation Announces Breakthrough in Candida auris Treatment
PRESS RELEASE published on 02/08/2023 at 14:00, 1 year 6 months ago Halberd Demonstrates Eradication of CDC Provided Antibiotic Resistant Bacteria
PRESS RELEASE published on 01/31/2023 at 14:00, 1 year 7 months ago Halberd to Conduct Animal Tests of Nasal Spray that Blocks Negative Effects of Head Trauma
PRESS RELEASE published on 01/24/2023 at 14:00, 1 year 7 months ago Halberd Agrees to Animal Testing at Mississippi State University
PRESS RELEASE published on 01/03/2023 at 14:00, 1 year 8 months ago Halberd Corporation 2022 Year End CEO Letter and 2023 Goals
Published on 09/07/2024 at 01:30, 1 day 1 hour ago Quantum Biopharma Receives Nasdaq Notification of Regaining Compliance with Nasdaq's Minimum Bid Price Requirement and Completes Debt Settlements
Published on 09/07/2024 at 00:30, 1 day 2 hours ago Cheech and Chong’s Global Holding Company Responds to California’s Proposed Emergency Hemp Ban
Published on 09/06/2024 at 23:15, 1 day 3 hours ago BluSky Carbon Announces Extension of Strategic Marketing Agreement
Published on 09/07/2024 at 14:00, 12 hours 58 minutes ago Litigation costs drive US liability claims by 57% over past decade, reveals Swiss Re Institute
Published on 09/06/2024 at 22:00, 1 day 4 hours ago Successful completion of preset purchase plan for the acquisition of Northern Data Group shares by CEO Aroosh Thillainathan
Published on 09/06/2024 at 18:45, 1 day 8 hours ago Molten Ventures Plc: POS-Transaction in Own Shares
Published on 09/06/2024 at 18:15, 1 day 8 hours ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 09/06/2024 at 17:56, 1 day 9 hours ago Funding Circle Plc: POS-Transaction in Own Shares
Published on 09/06/2024 at 18:00, 1 day 8 hours ago Declaration of voting rights at the end of August 2024